John Porteous has over 30 years’ experience in Wealth Management, having held senior executive roles across Financial Planning, Investment Management, Proposition and Digital. He joined Charles Stanley in 2019 as Head of Distribution and now serves as Managing Director of Central Financial Services and Chief Client Officer at Raymond James Wealth Management.
A regular speaker at key industry events, John has also held several influential positions within professional bodies, including Chairman of the Society of Financial Advisers, Director of the Institute of Financial Planning, and Council Member/Director of APFA.
In his current role, John has executive responsibility for oversight of Consumer Duty strategy across Raymond James Wealth Management.
A hands-on engineer with plenty of industry and R&D experience, who likes to experiment with new technologies, design and deploy novel solutions, and inspire the new generations of engineers and digital innovators.
A firm believer in the use of advanced technology and artificial intelligence to increase our quality of life, and to build a better society.
A promoter of best practices to ensure technologies are useful, safe and trustworthy.
You will find Dejanira leading teams of engineers and supply chain experts, sharing a vision of future technologies and digital capabilities with global leaders and future engineers, or bouncing ideas off other experts.
I am a Supply Chain Lead in Pfizer’s Global Clinical Supply organization, where I support the planning and execution of clinical trial supply. Over the past 10 years, I’ve worked across clinical supplies in multiple pharmaceutical companies, building a well-rounded understanding of end-to-end trial supply chain operations. In my current role, I partner closely with cross-functional teams across departments and divisions to anticipate trial needs, solve day-to-day challenges, and help ensure patients and sites receive the right materials at the right time.
Kerri Raso holds a MS in Clinical Investigation and has worked as a Clinical Systems Expert for over 25 years with positions ranging from system design consultant, IT manager, project/program manager and vendor manager. She has worked at both software vendors and on the sponsor side for large and very small biotech companies, spanning a wide array of therapeutic areas including rare disease and oncology. Over the last 15 years, her main passion has been IRT and IRT-integrated technologies such as drug forecasting, eConsent, eCOA and other clinical devices & wearables. Kerri is currently Director, IRT Systems overseeing IRT, eCOA and Central Imaging at Tango Therapeutics.
Tony is currently Associate Director, Clinical Supply Lead, at Alexion Pharmaceuticals, Inc. He joined the global clinical supply team in 2022
and has been supporting several late phase programs, including supply planning, vendor management and global distribution to support rare
disease patients in over 100 countries.
Prior to Alexion, he worked for Charles River Labs for five years as a Sr. Manager, Global Categories, leading category strategies, strategic
projects, Supply Chain analytics, contract negotiations and SRM & KPI Metrics. In addition, he led logistics planning for kidney care division at Fresenius. He redesigned the direct to patient delivery model and managed the RFP projects for both linehaul and last mile freight. In the
first 10 years of his career, he had various Operations roles at Trelleborg and Sinochem, both in Asia and the Greater Boston area.
He studied Supply Chain Management at MIT and is Lean Sigma Certified through Purdue University and ‘Certified Supply Chain
Professional’ (CSCP) through APICS. In his spare time, he volunteers for CSCMP as VP of Programs of the New England Roundtable.
